PraxyMonitoring – Improve and automate the detection and analysis of pharmacovigilance (PV) cases

Case detection

Why choose our solution?

Pharmacovigilance is a critical issue for patient safety and regulatory compliance. Traditional methods, often manual and prone to errors, are no longer sufficient in the face of growing data complexity. 

Our solution combines artificial intelligence , cutting-edge OCR and a proprietary anti-hallucination system to transform pharmacovigilance case detection and analysis.

Our key assets

Accuracy and completeness

Accurate data extraction from PubMed case reports and scientific journals, even from complex documents (PDFs, images, handwritten forms). Reduce data entry errors and save time.

Anti-hallucination system

Elimination of false positives and guarantee of reliable results, compliant with MedDRA and regulatory standards.

Intelligent Automation

Proactive detection of security signals, prioritization of critical cases and generation of reports in real time.

Enhanced compliance

Alignment with agency requirements (HAS, EMA, FDA, etc.), following typing standards (e.g. Medra) and reduction of non-compliance risks.

Predictive analysis

Early identification of emerging trends and risks using AI algorithms trained on global databases.

Unique technology for seamless pharmacovigilance

1. Next-generation OCR: accuracy and completeness

Unlike traditional solutions that struggle to process unstructured documents, our OCR optimized for pharmacovigilance :

• Recognizes and extracts data from a wide variety of sources: clinical reports, handwritten statements, scientific publications, social media, etc.
• Reduces transcription errors through continuous learning adapted to medical terminologies (MedDRA, WHO-DDE, etc.).
• Incorporates automatic validation to ensure data integrity before analysis.

Example : A scanned or photographed adverse event report is processed in real time, with an accuracy greater than 99%, compared to 80-85% for standard tools.

2. Anti-hallucination system: 100% reliable results

Traditional AI solutions can generate misinterpretations ("hallucinations"), jeopardizing patient safety and compliance. Our technology:

• Verifies each piece of data by cross-referencing multiple sources and applying strict business rules.
• Eliminates bias with a model trained on millions of cases validated by experts.
• Provides full traceability for every decision, essential in the event of an audit.

Comparison : Where other tools may suggest false links between a drug and an adverse effect, our system only offers correlations supported by evidence .

3. Intelligent workflow automation

From detection to reporting , our platform covers the entire process:

• Automated data collection (public databases, EHR, CRM, etc.).
• Sorting and prioritization of cases according to their severity (algorithms inspired by EMA and FDA best practices).
• Generation of reports compliant with regulatory formats (ICSR, PSUR, RMP), ready to be submitted to the authorities.

Time savings : Up to 70% reduction in time spent on repetitive tasks, allowing your teams to focus on strategic analysis.

Why choose Praxy.ai?

How we differentiate ourselves from the competition

Concrete use cases

1. Early detection of safety signals

• Problem : A rare adverse event is reported in unstructured clinical reports and goes unnoticed.
• Our solution : OCR identifies and extracts information, while AI corroborates it with other sources (social media, literature). The anti-hallucination system validates the signal before alerting.
• Result : 50% reduction in detection time compared to manual review.

2. Management of spontaneous declarations

• Problem : Handwritten or oral declarations (via call centers) are sources of errors.
• Our solution : Automatic transcription + AI validation, with direct integration into your database.
• Result : 90% of declarations processed without human intervention , with an error rate close to zero.

3. Audit and compliance

• Problem : Preparing for a regulatory audit takes weeks.
• Our solution : Instant generation of traceable reports, with attached documentary evidence.
• Result : 40% reduction in audit costs and elimination of non-compliance risks.

For whom?

Our solution is aimed at:

• Pharmaceutical laboratories : To accelerate risk detection and optimize pharmacovigilance costs.
• CRO (Contract Research Organizations) : To offer a differentiating service to their clients.
• Health authorities : To strengthen post-marketing surveillance.
• Hospitals and clinical centers : To improve the reporting of adverse events.

Testimonials and results

"During the pilot phase, the comparison over 1 million hours of activity showed that the AI ​​detected more confirmed cases of PV, with very few false alerts."

Request a demonstration

Discover how our technology can revolutionize your pharmacovigilance with:

• Faster risk detection .
• 100% reliable data .
• Effortless compliance .

📅 Schedule a demo 📩 Contact us

Q&A

Q: How do you ensure data confidentiality? A: Our platform is hosted on ISO 27001 and HIPAA certified servers, with end-to-end encryption.

Q: Is your solution compatible with our existing tools (Veeva, Argus, etc.)? A: Yes, we offer ready-to-use connectors and an API for custom integration.

Q: What is the expected ROI? A: Our clients see an average return on investment in less than 12 months , thanks to productivity gains and reduced non-compliance costs.